55 related articles for article (PubMed ID: 27366945)
1. Transcriptomic analysis identifies the shared diagnostic biomarkers and immune relationship between Atherosclerosis and abdominal aortic aneurysm based on fatty acid metabolism gene set.
Gu X; Yu Z; Qian T; Jin Y; Xu G; Li J; Gu J; Li M; Tao K
Front Mol Biosci; 2024; 11():1365447. PubMed ID: 38660376
[TBL] [Abstract][Full Text] [Related]
2. The Role of Lipid Metabolism in Gastric Cancer.
Cui MY; Yi X; Zhu DX; Wu J
Front Oncol; 2022; 12():916661. PubMed ID: 35785165
[TBL] [Abstract][Full Text] [Related]
3. Aldehyde Dehydrogenase 2 Family Member (ALDH2) Is a Therapeutic Index for Oxaliplatin Response on Colorectal Cancer Therapy with Dysfunction p53.
Wang WL; Batzorig U; Hung CS; Wei PL; Huang CY; Chang YJ
Biomed Res Int; 2022; 2022():1322788. PubMed ID: 35178443
[TBL] [Abstract][Full Text] [Related]
4. Monoacylglycerol lipase deficiency in the tumor microenvironment slows tumor growth in non-small cell lung cancer.
Kienzl M; Hasenoehrl C; Maitz K; Sarsembayeva A; Taschler U; Valadez-Cosmes P; Kindler O; Ristic D; Raftopoulou S; Santiso A; Bärnthaler T; Brcic L; Hahnefeld L; Gurke R; Thomas D; Geisslinger G; Kargl J; Schicho R
Oncoimmunology; 2021; 10(1):1965319. PubMed ID: 34527428
[TBL] [Abstract][Full Text] [Related]
5. Monoacylglycerol lipase reprograms lipid precursors signaling in liver disease.
Tardelli M
World J Gastroenterol; 2020 Jul; 26(25):3577-3585. PubMed ID: 32742127
[TBL] [Abstract][Full Text] [Related]
6. Effect of monoacylglycerol lipase on the tumor growth in endometrial cancer.
Li X; Gao S; Li W; Liu Z; Shi Z; Qiu C; Jiang J
J Obstet Gynaecol Res; 2019 Oct; 45(10):2043-2054. PubMed ID: 31357249
[TBL] [Abstract][Full Text] [Related]
7. Hydroxysteroid 11-Beta Dehydrogenase 1 Overexpression with Copy-Number Gain and Missense Mutations in Primary Gastrointestinal Stromal Tumors.
Li CF; Liu TT; Wang JC; Yu SC; Chen YY; Fang FM; Li WS; Huang HY
J Clin Med; 2018 Nov; 7(11):. PubMed ID: 30388854
[TBL] [Abstract][Full Text] [Related]
8. Microarray analyses reveal genes related to progression and prognosis of esophageal squamous cell carcinoma.
Qixing M; Gaochao D; Wenjie X; Anpeng W; Bing C; Weidong M; Lin X; Feng J
Oncotarget; 2017 Oct; 8(45):78838-78850. PubMed ID: 29108269
[TBL] [Abstract][Full Text] [Related]
9. MiRNA profiling of gastrointestinal stromal tumors by next-generation sequencing.
Gyvyte U; Juzenas S; Salteniene V; Kupcinskas J; Poskiene L; Kucinskas L; Jarmalaite S; Stuopelyte K; Steponaitiene R; Hemmrich-Stanisak G; Hübenthal M; Link A; Franke S; Franke A; Pangonyte D; Lesauskaite V; Kupcinskas L; Skieceviciene J
Oncotarget; 2017 Jun; 8(23):37225-37238. PubMed ID: 28402935
[TBL] [Abstract][Full Text] [Related]
10. Ezrin overexpression in gastrointestinal stromal tumors: an independent adverse prognosticator associated with the non-gastric location.
Wei YC; Li CF; Yu SC; Chou FF; Fang FM; Eng HL; Uen YH; Tian YF; Wu JM; Li SH; Huang WW; Li WM; Huang HY
Mod Pathol; 2009 Oct; 22(10):1351-60. PubMed ID: 19648886
[TBL] [Abstract][Full Text] [Related]
11. Heat shock protein 90 overexpression independently predicts inferior disease-free survival with differential expression of the alpha and beta isoforms in gastrointestinal stromal tumors.
Li CF; Huang WW; Wu JM; Yu SC; Hu TH; Uen YH; Tian YF; Lin CN; Lu D; Fang FM; Huang HY
Clin Cancer Res; 2008 Dec; 14(23):7822-31. PubMed ID: 19047110
[TBL] [Abstract][Full Text] [Related]
12. PLCB4 copy gain and PLCß4 overexpression in primary gastrointestinal stromal tumors: Integrative characterization of a lipid-catabolizing enzyme associated with worse disease-free survival.
Li CF; Liu TT; Chuang IC; Chen YY; Fang FM; Chan TC; Li WS; Huang HY
Oncotarget; 2017 Mar; 8(12):19997-20010. PubMed ID: 28212550
[TBL] [Abstract][Full Text] [Related]
13. Research progress on FASN and MGLL in the regulation of abnormal lipid metabolism and the relationship between tumor invasion and metastasis.
Zhang J; Song Y; Shi Q; Fu L
Front Med; 2021 Oct; 15(5):649-656. PubMed ID: 33973101
[TBL] [Abstract][Full Text] [Related]
14. Transcriptomic reappraisal identifies MGLL overexpression as an unfavorable prognosticator in primary gastrointestinal stromal tumors.
Li CF; Chuang IC; Liu TT; Chen KC; Chen YY; Fang FM; Li SH; Chen TJ; Yu SC; Lan J; Huang HY
Oncotarget; 2016 Aug; 7(31):49986-49997. PubMed ID: 27366945
[TBL] [Abstract][Full Text] [Related]
15. Overexpressed Fatty Acid Synthase in Gastrointestinal Stromal Tumors: Targeting a Progression-Associated Metabolic Driver Enhances the Antitumor Effect of Imatinib.
Li CF; Fang FM; Chen YY; Liu TT; Chan TC; Yu SC; Chen LT; Huang HY
Clin Cancer Res; 2017 Aug; 23(16):4908-4918. PubMed ID: 28442505
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
